6515--Monitor/Defibrillator

The Department of Veterans Affairs Veterans Integrated Service Network 22 seeks nine line items of portable defibrillator/monitor equipment for the VA Long Beach Healthcare System, with proposals due August 12 at 1:00 PM PDT. The procurement is set aside 100% for Service-Disabled Veteran-Owned Small Businesses (SDVOSB).

Place of performance is 5901 E 7th Street, Long Beach, California 90822. The solicitation seeks three Zoll X Series Monitor/Defibrillators with expansion packs (SpO2, Pacing, NIBP, IBP/Temp, EtCO2) and associated accessories including rechargeable batteries, charger adapters, thermal paper, factory warranty extensions, reusable patient cables, reusable sensors, transducer interface cables, and ECG cables on a brand-name or equal basis.

Salient characteristics include a lightweight portable design weighing less than 6 kg, 5-lead ECG monitoring, rectilinear biphasic waveform defibrillation, synchronized shock and noninvasive transcutaneous pacing capabilities, audio CPR quality feedback with artifact filtering during chest compressions, a monitor display no larger than 7 inches diagonal, cable compatibility with ZOLL R Series defibrillators, and capability to print ECG rhythm strips with trend summaries and treatment reports showing three waveforms. The device must support both AED advisory and manual defibrillation modes and optimize for EMS transport and on-scene care environments.

The contract is Firm-Fixed-Price with delivery required within 60 days of award. Offerors must be registered in SAM, provide an Authorized Distributor Letter from the manufacturer signed within 90 days, supply new products only (no gray market items), and provide complete Buy American Act compliance documentation including country of origin, domestic content percentages, and TAA status. Award goes to the lowest-priced offeror whose submission demonstrates that all equal-to items meet the specified salient characteristics. Amendment 0002, issued August 12, clarified the performance-based specifications and confirmed brand-name-or-equal treatment.